Adult ADHD Myths and What the Evidence Says

Adult ADHD attracts strong opinions, and many of them are stated as fact. Each myth below is paired with the best available evidence and with what that evidence cannot show. Where the honest answer is "partly", this page says so.

Myths about who has ADHD

Myth 1: ADHD is a childhood condition that people grow out of

Some do improve, but lasting recovery is uncommon. A follow-up of 558 children from a major US treatment study, tracked to an average age of 25, found that about 30% had a full remission at some point, and 60% of those later had a recurrence. Only 9.1% showed sustained recovery by the end of the study. Most participants (63.8%) moved between better and worse periods, and about 90% had residual symptoms into young adulthood.

What changes is the form. The National Institute of Mental Health notes that inattentive symptoms often persist with age while hyperactivity and impulsivity are more likely to decline.

Myth 2: If you were not diagnosed as a child, it cannot be ADHD

The criteria require that several symptoms were present before age 12. They do not require a childhood diagnosis. In the CDC's 2023 national survey, 55.9% of adults with a current diagnosis were diagnosed at 18 or older. See can you develop ADHD as an adult? for how those two facts fit together.

Myth 3: ADHD mostly affects boys and men

Among US adults with a current diagnosis in 2023, 55.8% were male and 44.2% female, a far narrower gap than in childhood. NIMH states that symptoms in girls and women are especially likely to have been missed early. Prescription data point the same way: between 2020 and 2021, the share of commercially insured adults filling a stimulant prescription rose faster among women than men in most age groups. The site covers this in ADHD in women and late diagnosis.

Myths about diagnosis

Myth 4: A quiz, a computer test or a brain scan can diagnose ADHD

The CDC says there is no single test to diagnose ADHD. CHADD adds that there is no single medical, physical or genetic test, and that neuropsychological tests do not diagnose it directly.

• Screeners. The six-question WHO adult screener for DSM-5 performed well in validation, yet its positive predictive value in the general population was 67.3%. About one positive screen in three was a false positive.
• Computerized tests. One widely marketed attention test holds an FDA 510(k) clearance from 2014. Clearance means the agency found the device substantially equivalent to an earlier one for use as an aid. It is not FDA approval and not a finding that the test diagnoses ADHD.
• Neuropsychological testing. A 2024 review in American Family Physician says it may increase accuracy in particular situations, such as when no outside information is available. It is optional, and useful selectively.

The comparison article ADHD screeners and tests explained goes through each tool.

Myth 5: Everyone has a little ADHD

Everyone loses keys and drifts off in meetings. The diagnosis requires more: at least five symptoms lasting six months, onset before age 12, symptoms in two or more settings, and clear impairment. CHADD's summary states that symptoms without significant impairment do not meet the criteria. In the CDC survey, 6.0% of adults reported a current diagnosis, which leaves about 94% who did not. The criteria are explained in plain language here.

Myths about treatment

Myth 6: Every adult with ADHD is on medication

In the 2023 CDC survey, 50.4% of adults with ADHD had been prescribed medication for it in the previous year, and 36.5% were receiving no treatment of any kind. The gap is wider in later life. A meta-analysis of adults 50 and older found that 2.18% met criteria on research scales, 0.23% had a clinical diagnosis and 0.09% were being treated.

These numbers do not prove that ADHD is under-diagnosed everywhere, and they do not rule out careless diagnosis in particular settings. Both problems can exist at once.

Myth 7: Medication is the only thing that helps (or therapy works just as well)

Neither version holds. Medication has the stronger evidence for core symptoms: in a 2018 network meta-analysis of randomized trials, both main stimulant classes and the non-stimulant atomoxetine outperformed placebo in adults at about 12 weeks.

Cognitive behavioral therapy helps too, on thinner evidence. A 2018 Cochrane review of 14 trials found that CBT added to medication did better than medication alone on clinician-rated symptoms, and its authors rated the evidence low quality. A 2025 analysis found that psychological treatments reduced symptoms on clinician ratings but not on patients' own ratings. The same analysis found no demonstrated benefit of medication on quality of life. CBT is best understood as an addition to medication, and the evidence does not show it to be an equal substitute. The site's article on treatment without medication discusses the non-drug options.

Myths about medication safety

Myth 8: ADHD medication is proven safe for the heart (or is known to cause heart disease)

A Swedish register study published in 2024 followed people aged 6 to 64 with ADHD and found that each additional year of medication use was associated with about 4% higher odds of cardiovascular disease, with the increase concentrated in the first three years. The signal was mainly high blood pressure and arterial disease.

The study was observational, so it shows an association and cannot show cause. It supports neither "proven safe" nor "causes heart disease". It does support what stimulant labels already require: checking blood pressure and pulse at intervals.

Myth 9: Taking a prescribed stimulant is the same as misusing drugs (or carries no misuse risk)

Taking a medication as prescribed is treatment. The risk of misuse is real, though, and the FDA required an updated boxed warning on all prescription stimulants in May 2023 covering misuse, abuse, addiction and overdose.

The data: national survey figures for 2024 show 1.4% of US adults misused a prescription stimulant in the past year. Among adults who use prescription stimulants, a 2025 study found that 25.3% reported some misuse and 9.0% met criteria for prescription stimulant use disorder, most of those cases mild. A family physicians' review reports that in 2021 about 66% of people who misused stimulants got them from family or friends with a prescription, which is why safe storage matters. See ADHD and substance use.

How to check a claim yourself

• Ask what was measured. A self-reported diagnosis, a clinician interview and a prescription fill are three different things.
• Ask how long. Most medication trials run about 12 weeks.
• Ask whether the study was a randomized trial or observational. Observational studies cannot prove cause.
• Be wary of round, unsourced numbers.

For the studies behind these answers, read does ADHD treatment work in adults? The practice's evaluation page explains how a diagnosis is reached.